Biocryst Pharmaceuticals
Clinical trials sponsored by Biocryst Pharmaceuticals, explained in plain language.
-
Eye injection study for diabetes-related vision loss ends early
Disease control TerminatedThis study tested a single injection of avoralstat into the eye for people with diabetic macular edema, a condition that causes vision loss in diabetes. Only 3 adults took part before the study was stopped early. The main goal was to check safety and see if the drug might help re…
Phase: PHASE1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
BCX9930 safety checked in PNH patients who benefited from treatment
Disease control TerminatedThis study looked at the long-term safety of BCX9930, an oral medication, for people with paroxysmal nocturnal hemoglobinuria (PNH) who had already benefited from the drug in a previous study. It included 28 participants and aimed to monitor side effects. The study was terminated…
Phase: PHASE2 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC